-
Pfizer lays out timeline for its COVID-19 vaccine and a new flu vaccine
In a teleconference announcing the company’s first-quarter 2021 earnings earlier this month, Pfizer laid out its timeline for when different…
-
The wonderful new trend of ‘peer review’ threads on Twitter
I’ve used Twitter since 2008, but never has it been more vital to my work and news diet than throughout…
-
More resources on variants for your COVID-19 reporting toolbox
Back in January, Bara Vaida, the AHCJ core topic leader for infectious disease, wrote a helpful post on resources for…
-
Don’t forget about coverage of other vaccines
Reading the news these days, it seems the word “vaccine” automatically refers to the COVID-19 vaccine, no matter the context.…
-
And now for something completely different
So much of the past 15 months has been nonstop reporting about COVID-19 for many health reporters. So once in…
-
Check here for comprehensive data on FDA-authorized COVID-19 vaccines
It can be challenging to keep track of all details associated with the authorization, data and ongoing studies related to…
-
New data resource lists research on infection prevention from COVID-19 vaccines
Since the COVID-19 vaccines were authorized by the FDA, one of the big questions has been how well they prevent…
-
New tip sheet helps you find the precisely right expert when you need them
I’ve written before about the importance of finding not just any expert but one with detailed expertise in the specific…
-
How to find the right outside expert with the relevant expertise for new study
How do you find the most appropriate outside experts to comment on a study you’ve been assigned if it’s on…
-
If AstraZeneca’s vaccine is authorized, be prepared to write those explainers
Just a day after AstraZeneca announced long-awaited interim results from its U.S. phase 3 trial earlier this week, the company…